Patent ID: 11918689
Assignee: TRIS PHARMA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 15:
16. The extended release oral clonidine aqueous suspension according to claim 15, wherein the suspension provides one or more of the pharmacokinetic parameters for clonidine of:
(a) an arithmetic mean Cmax (pg/mL) of about 350 pg/mL to about 450 pg/mL; and/or
(b) an arithmetic mean AUC0-∞ (hr-pg/mL) of about 12,500 hr-pg/mL to about 14,550 hr-pg/mL; and/or
(c) an arithmetic mean Tmax (hr) of about 15.5 hours to about 20.5 hour.